Skip to main content
Clinical Trials/NCT04838210
NCT04838210Active, not recruitingNot Applicable

Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care

Washington University School of Medicine5 sites in 1 country416 target enrollmentStarted: May 21, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
416
Locations
5
Primary Endpoint
Perinatal Depression

Study Overview

Brief Summary

This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
13 Years to — (Child, Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • English or Spanish speaking
  • ≤18 weeks' gestation
  • Established prenatal care at EleVATE site
  • High-risk for postpartum depression by ≥1 risk factor (personal/family history, baseline EPDS≥10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss)
  • Ability to attend group prenatal visits at specified days/times
  • Willingness to be randomized
  • Ability to give informed consent
  • Any patient that has received prenatal care in a group setting previously

Exclusion Criteria

  • Multiple gestation
  • Major fetal anomaly
  • Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting
  • Serious medical co-morbidity necessitating more care than can be safely provided in group setting

Arms & Interventions

Group Prenatal Care

Experimental

Group prenatal care model

Intervention: EleVATE Group Care (Behavioral)

Individual Prenatal Care

Active Comparator

Individual prenatal care

Intervention: Individual Prenatal Care (Behavioral)

Outcomes

Primary Outcomes

Perinatal Depression

Time Frame: 4-12 weeks Postpartum

Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome)

Perinatal Depression

Time Frame: Baseline visit

Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome)

Perinatal Depression

Time Frame: 28-40 week visit

Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome)

Secondary Outcomes

  • Preterm Birth(Delivery)
  • Anxiety(4-12 weeks Postpartum)
  • Social Support(4-12 weeks Postpartum)
  • Small for Gestational Age(Delivery)
  • Perceived Stress(4-12 weeks Postpartum)
  • Post-Traumatic Stress Disorder (PTSD)(Baseline Visit)
  • Race-Related Stress(Baseline visit)
  • Maternal Attachment (Postnatal)(4-12 Weeks Postpartum)
  • Maternal Attachment (Antenatal)(28-40 week visit)
  • Perceived Stress(Baseline visit)
  • Perceived Stress(28-40 week)
  • Anxiety(Baseline visit)
  • Anxiety(28-40 week visit)
  • Social Support(Baseline visit)
  • Social Support(28-40 week visit)
  • Maternal Attachment (Antenatal)(Baseline visit)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials